STOCK PURCHASE AGREEMENTStock Purchase Agreement • October 17th, 2011 • Genelink Inc • Services-medical laboratories • New York
This Stock Purchase Agreement (this “Agreement”) is made as of October 13, 2011 (the “Signing Date”), by and among Capsalus Corp., a Nevada corporation (the “Purchaser”) and GeneLink, Inc., a Pennsylvania corporation (the “Seller”).
GENELINK BIOSCIENCES AGREES TO SELL GENEWIZE LIFE SCIENCESGenelink Inc • October 17th, 2011 • Services-medical laboratories
ORLANDO, FL – Oct. 13, 2011 – GeneLink Biosciences, Inc. (OTCBB:GNLK), a leading consumer genomics biotech company, has finalized a definitive agreement with Capsalus Corp. (OTCBB:WELL), a public company operating in the health and wellness space, to sell the stock of its wholly owned direct-selling subsidiary GeneWize Life Sciences, Inc., pending GeneLink shareholder approval and other related terms. The deal enables GeneLink to leverage the strengths of its sales and marketing partners to accelerate its growth strategy and to focus on the company’s core competencies.
INTERIM MANAGEMENT AGREEMENTInterim Management Agreement • October 17th, 2011 • Genelink Inc • Services-medical laboratories • New York
THIS AGREEMENT (“Agreement”) is entered into this 13th day of October, 2011, effective as of October 1, 2011 by and among CAPSALUS CORP., a Nevada corporation with its principal place of business at 2675 Paces Ferry Road, Atlanta, GA 30339 (“Purchaser”), GENELINK, INC., a Pennsylvania corporation with its principal place of business at 317 Wekiva Springs Road, Suite 200, Longwood, FL 32779 (“GeneLink”) and GENEWIZE LIFE SCIENCES, INC., a Delaware corporation with its principal place of business at 317 Wekiva Springs Road, Suite 200, Longwood, FL 32779 (the “Company”) (Purchaser, GeneLink, and the Company are hereinafter collectively referred to as the “Parties”). All capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Stock Purchase Agreement (as hereinafter defined).
